Contracts Finder · Award
Recombinant Von Willebrand Factor
A public procurement published by NHS England via Contracts Finder.
- £250k
- Award value
- £250k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor
Key details
- Buyer
- NHS England
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- £250,000
- Tender value
- £250,000
- First published
- 22 Feb 2021
- Last updated
- 22 Feb 2021
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Shire Pharmaceuticals Ltd | 02031674 | 12 Jan 2021 | active | £250k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from NHS England
FAQs about this procurement
Who is the buyer for "Recombinant Von Willebrand Factor"?
Recombinant Von Willebrand Factor is a UK public-sector procurement published by NHS England via Contracts Finder.
Has "Recombinant Von Willebrand Factor" been awarded?
Yes — 1 award is recorded, with a reported total value of £250,000. The current lifecycle stage is "Award".
Which suppliers are involved in "Recombinant Von Willebrand Factor"?
1 supplier is linked: Shire Pharmaceuticals Ltd.
What is "Recombinant Von Willebrand Factor" worth?
The reported award value is £250,000.
When was "Recombinant Von Willebrand Factor" published?
It was first published on 22 Feb 2021 and last updated on 22 Feb 2021, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable